Last 11.60 INR
Change Today 0.00 / 0.00%
Volume 0.0
SNDP On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

sandu pharmaceuticals (SNDP) Snapshot

Open
11.60
Previous Close
12.19
Day High
11.60
Day Low
11.60
52 Week High
06/13/14 - 14.91
52 Week Low
05/13/14 - 8.37
Market Cap
82.1M
Average Volume 10 Days
1.7K
EPS TTM
1.10
Shares Outstanding
7.1M
EX-Date
--
P/E TM
10.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for SANDU PHARMACEUTICALS (SNDP)

Related News

No related news articles were found.

sandu pharmaceuticals (SNDP) Related Businessweek News

No Related Businessweek News Found

sandu pharmaceuticals (SNDP) Details

Sandu Pharmaceuticals Limited manufactures and markets ayurvedic medicines primarily in India. Its products include Berbenteron Pediatric Suspension for relief in children’s diarrhea; Berbenteron compound tablets for gastrointestinal disorders; Bilagyl to control of diarrhea and dysentery; Debix, a natural glucose regulator for the treatment of diabetes, polyurea, diabetic neuropathy, diabetic erectile dysfunction, and diabetic retinopathy; and Elegance oil, a medicated massage oil for neonates and infants. The company also provides Ephenin for the treatment of bronchial asthma and other respiratory disorders; Haemol Forte, a natural iron supplement; Madiphal Rasayan to treat anorexia, indigestion, mild constipation, vomiting, liver disorders, abdominal pain, and heart diseases; OSTEON-D, a natural calcium supplement; and Pregutero primarily for the treatment of IUGR, bad obstetric history, morning sickness, and anemia of pregnancy. In addition, it offers Sarak Churna to treat constipation, piles, and fistula; Shatari, a nutritive tonic for the nursing mother and the child; Stresan, a herbal tranquilizer; JAUNDEX for the treatment of jaundice and hepatitis; Vanari Kalpa for the treatment of oligospermia, erectile dysfunction, and general debility; Vimfix for vigor and vitality; Whoopin for cough; and PENTAZYME, a digestive enzyme stimulator. Sandu Pharmaceuticals Limited was founded in 1899 and is based in Mumbai, India.

Founded in 1899

sandu pharmaceuticals (SNDP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sandu pharmaceuticals (SNDP) Key Developments

Sandu Pharmaceuticals Limited Announces the Resignation of Prasanna S. Bhatkar as Chief Finance Officer

Sandu Pharmaceuticals Ltd. has informed that Chief Finance Officer Mr. Prasanna S. Bhatkar, has tendered his resignation on June 02, 2014, His resignation has been duly accepted by the Company Board. He will he relieved from the Company services after the Completion of due process and formalities.

Sandu Pharmaceuticals Ltd. Announces Audited Earnings Results for the Fourth Quarter and Year Ended March 31, 2014

Sandu Pharmaceuticals Ltd. announced audited earnings results for the fourth quarter and year ended March 31, 2014. For the quarter, the company reported total income from operations of INR 98.952 million against INR 260.655 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 5.018 million against INR 10.501 million a year ago. Profit from ordinary activates before tax was INR 3.837 million against INR 4.394 million a year ago. Net profit for the period was INR 1.705 million against INR 3.256 million a year ago. Basic and diluted earnings per share before extraordinary items were INR 0.24 against INR 0.46 a year ago. For year, the company reported total income from operations of INR 359.607 million against INR 301.892 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 15.519 million against INR 14.735 million a year ago. Profit from ordinary activates before tax was INR 8.232 million against INR 11.641 million a year ago. Net profit for the period was INR 4.962 million against INR 7.797 million a year ago. Basic and diluted earnings per share before extraordinary items were INR 0.70 against INR 1.10 a year ago.

Sandu Pharmaceuticals Limited, Board Meeting, May 30, 2014

Sandu Pharmaceuticals Limited, Board Meeting, May 30, 2014. Agenda: To consider audited results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNDP:IN 11.60 INR 0.00

SNDP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SNDP.
View Industry Companies
 

Industry Analysis

SNDP

Industry Average

Valuation SNDP Industry Range
Price/Earnings 16.5x
Price/Sales 0.2x
Price/Book 0.5x
Price/Cash Flow 7.9x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANDU PHARMACEUTICALS, please visit www.sandu.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.